Vibration once again. Maybe it is useful. What does your doctor and therapist think? Do they think at all?
Previous vibration posts so your doctor doesn't even have to do any research or thinking.
1. Effects of whole-body vibration on muscle architecture, muscle strength, and balance in stroke: A randomized controlled trial
2. Vibrating Glove May Enhance Sense of Touch
3. No specific effect of whole-body vibration training in chronic stroke: a double-blind randomized controlled study.
4. Efficacy of whole body vibration exercise in older people: a systematic review
5. Quicker and easier rehabilitation following a stroke - vibration
6. Vibration and stroke rehab
7. Vibrostimulation in Bobsleigh
8. 7-speed Secret Love Finger Fun Vibrator Vibration Massager with Sexy Dice
9. Foot drop - Step Sensor by Brownmed
10. Touchy-feely options for stroke rehabilitation
11. Stroke rehab glove combines mental practice and muscle stimulation to improve hand function
And the newest one here:
http://www.ohsu.edu/xd/about/news_events/news/2013/05-30-fda-clears-medical-devic.cfm
The Food and Drug Administration today granted 510(k) clearance to a
muscle and joint rehabilitation medical device developed by OHSU
Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.
AMES is an Oregon Health & Science University spinoff company
established to transform Dr. Cordo's OHSU research findings into a
rehabilitation medical device for use in hospitals and clinics. Today's
FDA clearance allows AMES to market and sell the device. AMES
anticipates delivering the device to hospitals and clinics in early
2014. The typical patient population that possibly receive treatment
with an AMES Device would include stroke victims and patients with
partial injuries to the spinal cord.
The AMES rehabilitation medical device uses robotic technology to
assist a patient in moving the affected limb while vibrating the muscle
receptors at the same time. During use, the patient’s input effort and
other parameters important in therapy are measured and recorded by the
AMES Device and displayed to the patient as real-time visual
biofeedback. The AMES Device can also perform several diagnostic tests
each time a patient is treated by the device to track progress for
clinicians and insurance providers.
Dr. Cordo’s research at OHSU involved applying muscle vibration to
the receptors in the muscle tendon at the same time as the joint is
being moved. This is thought to result in an exaggerated perception of
movement of the extremity, in the correct direction, at the time
movement is made. The central nervous system monitors the sensory output
of the muscles and when a signal is detected, the brain senses that
movement, thereby helping guide the motion. AMES has invested in the
application of these important findings into a commercial medical
device. This resulted in a device that is capable of delivering
combination therapy through a series of programmed treatment regimens
controlled via computer software.
“Taking stroke as an example, if a person survives the initial
injury, the probability is about 50 percent that he or she will never
recover any functional use of the affected limb,” said Dr. Cordo, a
professor in the OHSU Department of Biomedical Engineering and Chief
Technology Officer for AMES. “Clinicians have few options for the most
severely disabled people other than working around their disabilities.
How many other types of medical conditions can you think of where we
give up on curing the worst affected 50 percent of the affected
population? We don’t think this is acceptable, so over the last 10
years, we’ve been working to come up with an alternative that is
effective with the severely disabled, or at least able to bring them to
the point that other therapies will be effective. The AMES
rehabilitation device is the product of that decade of work.”
Current research shows that muscle vibration can help the brain
“locate” the muscles controlling the joint, to reduce joint tightness,
and to enhance sensation at the treated joint or joints. This enhanced
sensation is thought to help the brain re-establish communication with
the affected muscles.
A series of clinical studies with the AMES Device were conducted at
multiple sites across the United States, some with chronic and sub-acute
stroke patients and some with chronic spinal cord injury victims. These
studies have provided clinical evidence that the AMES approach improves
movement and strength in people with injuries to the brain and spinal
cord, in some cases restoring the ability to carry out independent
activities that were previously unattainable. The studies included
treating the arm, hand and the leg. Most of the participants who were
enrolled in these studies were considered to be very disabled when they
started AMES treatment.
Currently, in the United States alone, there are more than 10 million
people whose movement is profoundly limited by diseases of and injuries
to the brain and spinal cord. About half of these people are so
disabled that currently available therapies are not effective in
restoring normal movement. Recent rehabilitation research suggests that
at least some of these severely disabled people can recover functional
movement if the therapy focuses on the fundamental problems that prevent
movement, as with the AMES Device.
While the device cannot regain movement for certain types of central
nervous system injuries and diseases, such as where the spinal cord is
completely severed, the device can assist in regaining some movement in a
large number of patients.
"We are very excited about the prospect that AMES technology will
improve the lives of thousands of injury and stroke victims,” said Dr. Tim Stout, M.D., Ph.D., M.B.A.,
OHSU’s Vice President for Technology Transfer and Business Development.
“This is revolutionary technology that can change how we treat these
patients."
OHSU and Dr. Cordo have a significant financial interest in AMES
Technology, Inc., a company that may have a commercial interest in the
results of this research and technology. This potential individual and
institutional conflict of interest has been reviewed and managed by
OHSU.
The AMES device is patented technology and is exclusively licensed worldwide to AMES.
Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 28,972 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke.DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER, BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment